By Interestana AI Editorial — AI-drafted, human-overseen. How we report
Natural Cycles Partners With Wearable Companies

Natural Cycles, a company known for its FDA-cleared birth control and fertility tracking app, is actively pursuing partnerships with manufacturers of popular wearable devices. This strategic approach aims to leverage the existing hardware that consumers already own, thereby reducing the barrier to entry for new users and enhancing the accuracy and convenience of its services. The company recently announced a collaboration with Whoop, a performance optimization wearable. This partnership allows Natural Cycles users to integrate data from their Whoop devices, which track metrics like sleep, recovery, and strain, directly into the Natural Cycles app. This integration is designed to provide a more comprehensive understanding of a user's physiological state, which can be crucial for accurate fertility prediction.
Natural Cycles' core technology relies on tracking a user's basal body temperature (BBT) and other cycle indicators to identify fertile windows and predict menstruation. Traditionally, this required a dedicated thermometer. By integrating with wearables, Natural Cycles can potentially access continuous temperature data or other physiological signals that may correlate with cycle phases. This move signifies a broader trend in the digital health and FemTech (female technology) sectors, where interoperability and data aggregation are becoming increasingly important. Companies are recognizing that users are more likely to adopt and consistently use services that seamlessly fit into their existing digital ecosystems and hardware.
The strategy of working with established wearable brands like Whoop, and potentially others in the future, allows Natural Cycles to tap into a wider user base without requiring them to purchase new, specialized hardware. This is a significant advantage in a competitive market. Wearable devices from companies such as Apple, Fitbit, and Garmin already collect a wealth of physiological data, and Natural Cycles is positioning itself to be a key player in interpreting this data for reproductive health purposes. The company's FDA clearance for its contraceptive use adds a layer of credibility and regulatory approval that is vital in the health technology space.
This expansion into wearable integration is more than just a technological upgrade; it's a business strategy focused on accessibility and user experience. By making its sophisticated fertility tracking more accessible through devices people already wear daily, Natural Cycles is poised to increase its market penetration and provide more robust, data-driven insights into women's health. The company's commitment to scientific rigor, evidenced by its FDA clearance, combined with its embrace of wearable technology, positions it as a forward-thinking leader in the FemTech industry, aiming to empower users with precise and convenient reproductive health management tools.
Original source — read the full reporting at the publisher:
Read on Inc.Get the weekly AI digest
AI news + new model releases, weekly. Drafted by our agents, reviewed by humans.